Upcoming Medical Conferences in Bethesda

22nd International 3S Symposium is organized by STAR Institute for Sensory Processing Disorder (SPD) and will be held from Nov 15 - 16, 2019 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Who should attend: Occupational therapists, speech language pathologists, physical therapists, special education teachers, psychologists, early intervention specialists, nurses, physicians, mental health professionals, parents and other individuals seeking a better understanding of Sensory Processing Disorder. Continuing Education: 2-day Symposium: 11 Hours (1.1 AOTA CEU) 1-day: Symposium: 5.5 Hours (.55 AOTA CEU) Friday, November 15 OR Saturday, November 16 Attend in person or participate via live-stream from anywhere with internet access!* Join us for the 22nd International 3S Symposium as we discuss ​the primary role sensory processing and sensory motor integration ​play in everything that we do and what that means for participation, function and self-actualization. ​Speakers from across a variety of disciplines will delve into the interplay of sensory processing and sensory motor experience with mental health domains and meaningful participation. This knowledge will transform your clinical practice by reframing challenging behaviors, supporting improved function and maximizing experiences of success for your clients and their families.  Explore the crucial role sensory processing/sensory motor experience plays in shaping human development. We will examine the impact of sensation on ‘sense of self’ and self-agency. An expanded focus will include how the ‘self’ interacts within the external environment. Discover how both positively affect the individual’s relationships within the family and the community, as well as positively grow the individual’s physical capacities to interact in the world. This conference is designed for clinicians, researchers and professionals working with neurodiverse populations, including: occupational therapists, physical therapists, speech language pathologists, educators, child development specialists and mental health professionals. We also welcome parents, caregivers and carers, as well as individuals with disordered sensory processing. Professionals may also choose to attend the Pre-Symposium Professional Workshop* or Pre-Symposium Parent Workshop taking place the day before the Symposium. *The November 14, 2019 Pre-Symposium Professional Workshop will not be livestreamed.

Fundamentals of Aseptic Processing - Option 6 is organized by Parenteral Drug Association (PDA) and will be held from Dec 02 - 05, 2019 at Parenteral Drug Association, Bethesda, Maryland, United States of America. This Conference has been approved for a maximum of 2.4 CEUs. Who Should Attend This training course is intended for professionals who are new to sterile drug manufacturing. Departments Manufacturing, Quality Assurance, Quality Control, Engineering Roles Management, Operator/Technician, Analyst, Specialist, Engineer Course Description: This training course will help you understand the basic principles, processes and systems related to aseptic processing. During this training course, you will learn about environmental monitoring systems, facility cleaning and disinfection, aseptic cleanroom operations, filtration, sterilization, aseptic process simulation (media fill), and regulatory requirements. Hands-on activities will include gowning qualification, facility cleaning and disinfection, performing aseptic processes in ISO 5 conditions and performing visual inspection. Learning Objectives • Evaluate current aseptic processing procedures • Assess potential risks of product contamination using airflow visualization techniques • Determine the necessary components of an effective environmental monitoring program • Describe the importance of filter integrity testing • Examine cleanroom fill operations to ensure appropriate interventions and observations occur • Review basic microbiology concepts and techniques to multiple aspects of aseptic processing • Demonstrate an understanding of sanitization techniques and disinfectant evaluation by properly operating different cleaning systems • Interpret regulatory requirements for manufacturing sterile products produced by aseptic processing Additional details will be posted as soon as information is available.

Building Interdisciplinary Research Careers in Women's Health (BIRCWH) - Annual Meeting is organized by NIH Office of Research on Women's Health (ORWH) and will be held on Dec 11, 2019 at Natcher Conference Center, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

Single Use Systems for the Manufacturing of Parenteral Products is organized by Parenteral Drug Association (PDA) and will be held from Dec 12 - 13, 2019 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in with the implementation of Single Use Systems for drug substance and drug product manufacturing. Departments Quality Assurance, Manufacturing, Regulatory Affairs, Supply Chain, Product Development, Engineering Roles Managers, Specialists, Scientists, Engineers Accreditation: CONTINUING EDUCATION FOR PHARMACISTS: CEUs: 1.2 CONTINUING EDUCATION FOR PROFESSIONAL ENGINEERS: New Jersey: The credit value of this course is 12 CPC credits. North Carolina: The credit value of this course is 12 PDH credits. Description: This training course will provide attendees with critical concepts to consider when implementing an SUS strategy in a pharmaceutical manufacturing process. These concepts are intended to be valid both for chemically synthesized, small molecules and for bioprocesses that produce large-molecule, biopharmaceutical products. The training course will discuss SUSs that are in either direct or indirect contact with the raw materials, intermediates, intermediate products, pharmaceutical drug substances or drug products. Objectives: • Describe the necessary considerations and steps to accomplish a successful evaluation and implementation of an SUS strategy • Define process operating parameters and requirements necessary when examining single use solutions • Compare and contrast single use technology and multi-use technology • Assess risk by considering the potential for the SUS to interact with product or process fluids • Outline supplier control strategies to ensure successful SUS implementation Additional details will be posted as soon as information is available.

Strategies for Clinical Imaging in Diabetes is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and will be held from Jan 13 - 15, 2020 at National Institutes of Health campus, Bethesda, Maryland, United States of America. Description: The ability to noninvasively image the cell types of the pancreatic islet and their function, particularly the beta cell, would allow diabetes researchers to observe and learn about the natural history of diabetes in living human beings. Most of the information we have currently about the fate of the insulin-producing cells comes from single snapshots taken in cadaver pancreas from people in various stages of diabetes. At this time, there are several promising imaging agents in various stages of development and validation. Objectives: This workshop is designed to provide a forum for discussion of the state of the art of in vivo imaging of the pancreatic islet beta cell mass and function, and the next steps toward this important goal. Additional details will be posted as soon as information is available.

Imaging the Pancreas in Diabetes, and Benign and Malignant Exocrine Pancreatic Disease is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and will be held from Jan 13 - 15, 2020 at NIH Campus, Bethesda, Maryland, United States of America. Background: There are a large number of questions that are arising from clinical experience in the exocrine pancreas field that impact issues of diabetes pathogenesis, and vice versa—the observation of substantial changes in exocrine size and likely architecture that precede diabetes onset is one striking example of this. Other examples include inflammation and changes in organ blood flow, and the incidence of diabetes (both T1D and T2D) with exocrine diseases of various sorts. Treatment of a disease with an endocrine or exocrine pathogenesis can affect the function (good and bad) of the entire pancreas. It has become clear that while the endocrine and exocrine pancreas are studied by different communities, and the diseases are treated by people in different medical disciplines, there is a great deal to be learned at the intersection. Imaging of the pancreas is at that intersection. Many of the goals for imaging in the pancreas are similar for endocrinologists and pancreatologists, and include size, architecture and tissue physical properties such as stiffness, vasculature, nerves, inflammation, fibrosis and fat deposition. Even imaging goals specific to different disciplines, such as the goals to image islet and beta cell mass and function or to visualize tumors, can yield information that is likely to inform both communities of scientists and clinicians. Objectives: The goal of this symposium is to showcase the use of imaging in the pancreas to detect and explore the pathogenesis of diabetes, pancreatic cancers, pancreatitis and other pancreatic diseases, in humans and model systems. The emphasis is on observations and biology from the fields of diabetes and pancreas disease research that can potentially inform each other. Additional details will be posted as soon as information is available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Jan 31, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

Compounding Pharmacy - Aseptic Operations - Option 1 is organized by Parenteral Drug Association (PDA) and will be held from Feb 03 - 05, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments Quality Control, Pharmacy Roles Supervisor, Analyst, Microbiologist, Pharmacist, Technician Accreditation: CEUs: 1.8 CONTINUING EDUCATION FOR PROFESSIONAL ENGINEERS: New Jersey: The credit value of this course is 18 CPC credits. North Carolina: The credit value of this course is 18 PDH credits. Description: In this training course, you will improve your understanding of microbial control and prevention of cross contamination for better quality compounded preparations. You will gain skills in aseptic technique by participating in hands-on activities such as environmental monitoring, smoke studies, gowning, and aseptic filling of media. Topics will include current issues in compounding pharmacy, cleaning, sterilization and sanitization, and USP <797> and <800>. Objectives: • Demonstrate how to achieve and maintain environmental control • Demonstrate how to achieve sterilization and differentiate from sanitization • Examine use and limitations of unidirectional HEPA filtered air • Explain cleaning and the role of materials of construction • Interpret the revised USP <797> and <800> Additional details will be posted as soon as information is available.

Compounding Pharmacy - Key Concepts in Microbiological Quality Control - Option 1 is organized by Parenteral Drug Association (PDA) and will be held on Feb 07, 2020 at Parenteral Drug Association, Bethesda, Maryland, United States of America. Who Should Attend? This training course is intended for professionals who are involved in compounding pharmacy. Departments: Quality Control, Quality Assurance, Quality Systems, Technical Operations, Training Roles: Pharmacist, Auditor, Analyst, Microbiologist, Virologist, Supervisor, Manager Accreditation: CEUs: 0.6 Continuing Education for Professionals Engineers: New Jersey: The credit value of this course is 6 CPC credits. North Carolina: The credit value of this course is 6 PDH credits. Description: Many of the regulations for compounding pharmacies have changed over recent years, with resulting requirements looking more like those applied to pharmaceutical manufacturing. As expectations have evolved so quickly for compounders, there has been a concordant need to quickly learn about new expectations and be prepared to put those into place for day-to-day practice. This training course will help close the knowledge gap about how compounders should be performing their microbiological QC testing, as well as control measures that should be implemented to contribute toward sterility assurance of products. Objectives: • Explain the importance of testing in the overall quality program in the compounding facility • Assess when and what to test when considering microbiological quality of product • Evaluate appropriate methods and equipment to use in microbiological QC testing • Review and interpret micro QC results to examine whether the compounded product is safe and the compounding process and facility is performing as expected • Examine current regulations and how they should be appropriately applied in different compounding settings

2020 American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting is organized by American Society for Experimental Neurotherapeutics (ASENT) and will be held from Mar 02 - 05, 2020 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Description: The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems. Additional details will be posted as soon as they are available.